No Data
XTL Biopharmaceuticals Expands With AI Company Acquisition
Social Proxy Will Operate as Fully Owned Subsidiary of XTL >XTLB
XTL Completed The Acquisition Of The Social Proxy And A Private Placement Of $1.5 Million >XTLB
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
XTL Biopharmaceuticals Will Issue ADSs Representing 44.6% of Issued and Outstanding Shr Cap to Hldrs of Social Proxy >XTLB
XTL Biopharmaceuticals Enters Agreement To Acquire AI Web Data Company The Social Proxy; Secures $1.5M In Private Placement
No Data
No Data
